bio - Miraca Life Sciences

Riccardo Valdez, MD
Vice President and Medical Director, Hematopathology
A C A D E M I C A N D A D M I N I S T R AT I V E E X P E R I E N C E
2011-2014 Chair, Division of Hematopathology, Department of Laboratory
Medicine and Pathology, Mayo Clinic in Arizona
Medical Director, Hematology and Histocompatibility
Laboratories
[email protected]
office: 602-648-3614
2006-2011
Section Head, Hematopathology, Department of Laboratory
Medicine and Pathology, Mayo Clinic in Arizona
Medical Director, Hematology and Flow Cytometry Laboratories
2005-2006
Director, Hematopathology Fellowship Training Program,
Department of Pathology, University of Michigan Health System
and Medical School
ACADEMIC APPOINTMENTS
2006-2014
Assistant Professor, Department of Laboratory Medicine and
Pathology, Mayo Clinic College of Medicine
2001-2006
Clinical Assistant Professor, Department of Pathology, University
of Michigan Medical School
POSTDOC TOR AL TR AINING
2000-2001
Hematopathology Fellow, Department of Pathology,
University of Michigan Medical School
1999-2000
Surgical Pathology Fellow, Department of Pathology,
University of Michigan Medical School
1997-1999
Chief Resident, Department of Pathology,
University of Michigan Medical School
1995-1999
Resident, Anatomic and Clinical Pathology,
University of Michigan Medical School, Department of Pathology
E D U C AT I O N
1995 M.D., University of Michigan Medical School, Ann Arbor, MI
1990 B.S, University of Arizona,
Tucson, AZ
C E R T I F I C AT I O N S
American Board of Pathology, Anatomic and Clinical Pathology, and Hematologic Pathology
PROFESSIONAL SOCIETIES
American Society of Hematology American Association for Cancer Research
Society for Hematopathology
International Society for Laboratory Hematology
American Society for Histocompatibility and
Immunogenetics
S E L E C T E D P U B L I C AT I O N S
Schild MH, Wong WW, Valdez R, Leis JF. Primary pulmonary
classical Hodgkin lymphoma: A case report. J Surg Oncol. 2014
Apr 29.
Bogenberger JM, Kornblau SM, Pierceall WE, Lena R, Chow
D, Shi CX, Mantei J, Ahmann G, Gonzales IM, Choudhary
A, Valdez R, et al. BCL-2 family proteins as 5-Azacytidinesensitizing targets and determinants of response in myeloid
malignancies. Leukemia. 2014 Jan 23.
Najib MQ, Vinales KL, Paripati HR, Kundranda MN,
Valdez R, Rihal CS, Chaliki HP. An Unusual Presentation of
Hemolytic Anemia in a Patient with Prosthetic Mitral Valve.
Echocardiography 2011 Mar 31.
Braggio E, Keats JJ, Leleu X, Van Wier S, Jimenez-Zepeda VH,
Valdez R, et al. Identification of copy number abnormalities
and inactivating mutations in two negative regulators of
nuclear factor-kappaB signaling pathways in Waldenstrom’s
macroglobulinemia. Cancer Res 2009 Apr 15; 69(8):3579-88.
Chesi M, Robbiani DF, Sebag M, Chng WJ, Affer M, Tiedemann
R, Valdez R, et al. AID-dependent activation of a MYC
transgene induces multiple myeloma in a conditional mouse
model of post-germinal center malignancies. Cancer Cell
2008;13(2):167-180.
Chng WJ, Mulligan G, Bryant B, Remstein E, Valdez R,
Dogan A, Fonseca R. The centrosome index is a powerful
prognostic marker in myeloma and identifies a cohort of
patients that may benefit from aurora kinase inhibition. Blood
2008;111(3):1603-1609.
To order Miraca Life Sciences Hematopathology Services
or to speak with a Miraca Life Sciences representative, call
1.855.856.0656
or visit us online at MiracaLifeSciences.com
© 2015 Miraca Life Sciences, Inc. All rights reserved. HE1120 5.15
Keats JJ, Fonseca R, Chesi M, Schop R, Baker A,Chng W-J, Van
Wier S, Tiedemann R, Shi C-X, Sebag M, Braggio E, Henry T, Zhu
Y-X, Fogle H, Price-Troska T, Ahmann G, Mancini C, Brents LA,
Kumar S, Greipp P, Dispenzieri A, Bryant B, Mulligan G, Bruhn
L, Barrett M, Valdez R, Trent J, Stewart AK, Carpten J, Bergsagel
PL. Promiscuous Mutations Activate the Non-Canonical NF-kB
Pathway in Multiple Myeloma. Cancer Cell 2007;12:131–144.
Rawal A, Schnitzer B, Finn WG, Valdez R. Site-specific
morphologic variations in extranodal marginal zone B-cell
lymphoma (EMZL). Accepted for publication. Arch Pathol Lab
Med 2007;131:1673-1678.
Yilmaz OH, Valdez R, Ferguson DO, Morrison SJ. Pten
dependence distinguishes hematopoietic stem cells from
leukemia-initiating cells. Nature 2006; 441(25):475-482.
BOOK CHAPTERS
Valdez R, Zutter. Hematopathology (chapter 20). In: Rubin’s
Pathology: Clinicopathologic Foundations of Medicine 7th
Edition, Lippincott, Williams, and Wilkins, 2014.
Valdez R, Zutter M, Rubin R. Hematopathology (chapter
20). In: Rubin’s Pathology: Clinicopathologic Foundations of
Medicine 6th Edition, Lippincott, Williams, and Wilkins, 2010.
Fonseca R, Valdez R. Laboratory Approach to Diagnosis
in Multiple Myeloma. In: Diagnostic Techniques in
Haematological Malignancies. Erber WN, editor. Cambridge
University Press, 2010.
Schnitzer B, Valdez R. Molecular and cellular biology of
Hodgkin’s lymphoma. In: Hematopathology in Oncology.
Finn, WG, Peterson LC, eds. Kluwer Academic Publishers,
Boston, 2004.